Baker Ellis Asset Management LLC Abb Vie Inc. Transaction History

Baker Ellis Asset Management LLC

$695 Million
Q3 2024

A detailed history of Baker Ellis Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 7,343 shares of ABBV stock, worth $1.23 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,343

Previous 6,755 8.7%

Holding current value

$1.23 Million

Previous $1.16 Million 25.22%

% of portfolio

0.21%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $96,337 - $117,206	588 Added 8.7%	7,343 $1.45 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $78,311 - $89,229	-490 Reduced 6.76%	6,755 $1.23 Million
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $1,651 - $1,859	12 Added 0.17%	7,245 $1.12 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $82,291 - $95,264	-616 Reduced 7.85%	7,233 $1.08 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $53,004 - $65,960	-400 Reduced 4.85%	7,849 $1.06 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $14,461 - $16,654	-100 Reduced 1.2%	8,249 $1.31 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $28,215 - $33,837	-204 Reduced 2.39%	8,349 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $17,447 - $20,010	130 Added 1.54%	8,553 $1.15 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $55,598 - $70,683	404 Added 5.04%	8,423 $1.29 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $41,496 - $47,104	390 Added 5.11%	8,019 $871,000
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 1.29%	7,629 $859,000
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $17,902 - $19,708	-175 Reduced 2.21%	7,729 $836,000
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $7,244 - $9,780	-90 Reduced 1.13%	7,904 $847,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $10,738 - $12,603	-125 Reduced 1.54%	7,994 $700,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $905,015 - $1.13 Million	-12,547 Reduced 60.71%	8,119 $719,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $34,639 - $41,646	-550 Reduced 2.59%	20,666 $1.57 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $19,710 - $25,194	-300 Reduced 1.39%	21,216 $1.54 Million
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $34,713 - $40,855	-450 Reduced 2.05%	21,516 $1.73 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $107,900 - $133,069	-1,386 Reduced 5.94%	21,966 $2.03 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $44,455 - $49,420	500 Added 2.19%	23,352 $2.21 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $22,445 - $26,557	-250 Reduced 1.08%	22,852 $2.12 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $115,012 - $154,012	-1,250 Reduced 5.13%	23,102 $2.19 Million
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $65,378 - $71,693	-730 Reduced 2.91%	24,352 $2.36 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $1.75 Million - $2.24 Million	25,082	25,082 $2.23 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.

Account

Baker Ellis Asset Management LLC Abb Vie Inc. Transaction History